Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Value Peer-spectives
Filter by Topic
ASCO’s Value Framework
Commentary
Employers’ Perspective
Letter to our Readers
Oncologist–Patient Communication
Patient Communication
Patient Perspective
Payer’s Perspective
Practice Management
Testimonials
The Patient Perspective
Value in Oncology
Value Propositions
VBCC Perspectives
HHS Allocates $1.9 Million to Establish Telehealth Programs for Underserved Populations
Value Propositions
,
Value Peer-spectives
February 2013, Vol 4, No 2
The HHS has allocated $1.9 million for new telehealth regional resource centers to serve rural and medically underserved populations.
Read Article
AACR Is Launching Cancer Immunology Research Journal
Value Propositions
,
Value Peer-spectives
February 2013, Vol 4, No 2
The American Association for Cancer Research (AACR) has announced the launch of its newest online journal, Cancer Immunology Research, in the spring at the AACR 2013 annual meeting.
Read Article
Starr Cancer Consortium Awards $5 Million to 5 Research Teams to Advance Patient Care
Value Propositions
,
Value Peer-spectives
February 2013, Vol 4, No 2
The Starr Foundation’s sixth Starr Cancer Consortium (SCC) Grant Competition awarded $5 million to 5 cancer research teams focusing on discovering new cancer mechanisms related to genetic mutations or epigenetic involvement in a variety of cancers.
Read Article
New Medicare Rules Will Save Providers $676 Million Annually
Value Propositions
,
Value Peer-spectives
February 2013, Vol 4, No 2
Removing Medicare regulations that are deemed unnecessary or unjustifiably burdensome on providers and hospitals would save nearly $676 million annually, and $3.4 billion over 5 years, through a rule proposed by the Centers for Medicare & Medicaid Services (CMS) in support of President Obama’s call on federal agencies to modify and streamline regulations on business.
Read Article
Novel Drug Targets Aggressive Form of NHL, Avoiding Chemotherapy a Goal
Value Propositions
,
Value Peer-spectives
January 2013, Vol 4, No 1
Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma (NHL) and a common type of cancer.
Read Article
First Group to Test Nanoparticles for the Treatment of Lung Cancer
Value Propositions
,
Value Peer-spectives
January 2013, Vol 4, No 1
Cancer Treatment Centers of America (CTCA) in Philadelphia, PA, is the first US center to investigate the use of nanotherapy for the treatment of metastatic lung cancer.
Read Article
Genomics Can Reduce Healthcare Disparities
Value Propositions
,
Value Peer-spectives
January 2013, Vol 4, No 1
Read Article
First Genomic Biomarker in Development for Multiple Myeloma
Value Propositions
,
Value Peer-spectives
January 2013, Vol 4, No 1
Empire Genomics is developing the first molecular diagnostic test for multiple myeloma (MM) using a novel genomic biomarker from Emory University that will allow providers to select the right treatments for the right patients based on their genetic profile.
Read Article
Two Genetic Signatures Can Help Identify Patients with Aggressive Prostate Cancer
Value Propositions
,
Value Peer-spectives
October 2012, Vol 3, No 7
The search for better diagnostic tools for prostate cancer continues, with current test modalities leaving much room for improvement.
Read Article
Novel Best Test to Guide Therapy in Children with Acute Myeloid Leukemia
Value Propositions
,
Value Peer-spectives
October 2012, Vol 3, No 7
Early treatment response is a strong predictor of long-term outcomes in children with acute myeloid leukemia (AML); it can further help to determine whether an aggressive treatment approach is needed.
Read Article
Page 9 of 16
4
5
6
7
8
9
10
11
12
13
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Navigating the Complex Landscape of Oral Cancer Medication
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
Wayne Kuznar
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma